Un peu moins de répit pour les cancers du foie ?

Jean Rosenbaum; Ludovic Ménard; Valérie Haurie; Danièle Taras

doi:doi:10.1051/medsci/200723111029

Accès gratuit

Numéro		Med Sci (Paris) Volume 23, Numéro 11, Novembre 2007


Page(s)		1029 - 1031
Section		Nouvelles
DOI		http://dx.doi.org/10.1051/medsci/200723111029
Publié en ligne		15 November 2007

Blanc JF, Lalanne C, Plomion C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005; 5 : 3778–89.
Shen X, Mizuguchi G, Hamiche A, et al. A chromatin remodelling complex involved in transcription and DNA processing. Nature 2000; 406 : 541–4.
Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000; 102 : 463–73.
Puri T, Wendler P, Sigala B, et al. Dodecameric structure and ATPase activity of the human TIP48/TIP49 complex. J Mol Biol 2007; 366 : 179–92.
Bauer A, Chauvet S, Huber O, et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J 2000; 19 : 6121–30.
Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000; 5 : 321–30.
Kim JH, Kim B, Cai L, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005; 434 : 921–6.
Rousseau B, Ménard L, Haurie H, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007; 46 : 1108–18.
Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci 2005; 118 : 3117–29.
Cho SG, Bhoumik A, Broday L, et al. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol Cell Biol 2001; 21 : 8398–413.
Talantov I, Mazumder A, Yu JX, et al, Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11 : 7234–42.
Graudens R, Boulanger V, Mollard C, et al, Deciphering cellular states of innate tumor drug responses. Genome Biol 2006; 7 : R19.
Sanchez-Carbayo C, Socci ND, Lozano J, et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006; 24 : 778–89.

[1] Blanc JF, Lalanne C, Plomion C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005; 5 : 3778–89.

[2] Shen X, Mizuguchi G, Hamiche A, et al. A chromatin remodelling complex involved in transcription and DNA processing. Nature 2000; 406 : 541–4.

[3] Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000; 102 : 463–73.

[4] Puri T, Wendler P, Sigala B, et al. Dodecameric structure and ATPase activity of the human TIP48/TIP49 complex. J Mol Biol 2007; 366 : 179–92.

[5] Bauer A, Chauvet S, Huber O, et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J 2000; 19 : 6121–30.

[6] Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000; 5 : 321–30.

[7] Kim JH, Kim B, Cai L, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005; 434 : 921–6.

[8] Rousseau B, Ménard L, Haurie H, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007; 46 : 1108–18.

[9] Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci 2005; 118 : 3117–29.

[10] Cho SG, Bhoumik A, Broday L, et al. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol Cell Biol 2001; 21 : 8398–413.

[11] Talantov I, Mazumder A, Yu JX, et al, Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11 : 7234–42.

[12] Graudens R, Boulanger V, Mollard C, et al, Deciphering cellular states of innate tumor drug responses. Genome Biol 2006; 7 : R19.

[13] Sanchez-Carbayo C, Socci ND, Lozano J, et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006; 24 : 778–89.

Prix Nobel 2012